Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27806681 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL7573099 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL27692872 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL11806604 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL2404354 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL6681848 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL6685358 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL14636124 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL22734895 | 1.00 | HTR2A (0.45) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA | |
| SCHEMBL28516127 | 0.98 | HTR2A (0.44) | HTR2ACSNK1ECYP19A1SIGMAR1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421779-B2 | Carbazole compound having anti-virus activity | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2019-09-24 | — | — | US | disclosed |
| CN-109265468-A | Small molecule containing anti-aromaticity indacene unit and its application in photovoltaic | 四川大学 | 2019-01-25 | — | — | CN | disclosed |
| US-20180057527-A1 | CARBAZOLE COMPOUND HAVING ANTI-VIRUS ACTIVITY | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2018-03-01 | — | — | US | disclosed |
| CN-103421045-A | Synthesis of phosphine ligand and application of phosphine ligand in olefine hydroformylation catalysis reaction | UNIV EAST CHINA SCIENCE & TECH | 2013-12-04 | — | — | CN | disclosed |
| US-5817775-A | HYDROFORMYLATION CATALYST | CELANESE INTERNATIONAL CORPORATION (US) | 1998-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057527-A1 | CARBAZOLE COMPOUND HAVING ANTI-VIRUS ACTIVITY | ZC3HAV1, ZC3HAV1L, GTF3C3 | HTR2A 4713/4885CSNK1E 175/4885CYP19A1 2916/4885 |
| US-10421779-B2 | Carbazole compound having anti-virus activity | ZC3HAV1, ZC3HAV1L, GTF3C3 | HTR2A 4713/4885CSNK1E 175/4885CYP19A1 2916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.